Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Br J Ophthalmol

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WANG LZ, Cheung CY, Tapp RJ, Hamzah H, et al
    Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
    Br J Ophthalmol. 2017 Mar 14. pii: bjophthalmol-2016-310002.
    PubMed     Text format     Abstract available


  2. SHIMURA M, Yasuda K, Motohashi R, Kotake O, et al
    Aqueous cytokine and growth factor levels indicate response to ranibizumab for diabetic macular oedema.
    Br J Ophthalmol. 2017 Mar 7. pii: bjophthalmol-2016-309953.
    PubMed     Text format     Abstract available


  3. ROMERO-AROCA P, Navarro-Gil R, Valls-Mateu A, Sagarra-Alamo R, et al
    Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study.
    Br J Ophthalmol. 2017 Mar 7. pii: bjophthalmol-2016-310063.
    PubMed     Text format     Abstract available


    February 2017
  4. NEELAM K, Goenadi CJ, Lun K, Yip CC, et al
    Putative protective role of lutein and zeaxanthin in diabetic retinopathy.
    Br J Ophthalmol. 2017 Feb 23. pii: bjophthalmol-2016-309814.
    PubMed     Text format     Abstract available


  5. WICKREMASINGHE SS, Fraser-Bell S, Alessandrello E, Mehta H, et al
    Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema.
    Br J Ophthalmol. 2017 Feb 22. pii: bjophthalmol-2016-309882.
    PubMed     Text format     Abstract available


    January 2017
  6. NERIYANURI S, Pardhan S, Gella L, Pal SS, et al
    Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy.
    Br J Ophthalmol. 2017 Jan 20. pii: bjophthalmol-2016-309641.
    PubMed     Text format     Abstract available


  7. GUPTA P, Thakku SG, Sabanayagam C, Tan G, et al
    Characterisation of choroidal morphological and vascular features in diabetes and diabetic retinopathy.
    Br J Ophthalmol. 2017 Jan 5. pii: bjophthalmol-2016-309366.
    PubMed     Text format     Abstract available


  8. EGAN C, Zhu H, Lee A, Sim D, et al
    The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.
    Br J Ophthalmol. 2017;101:75-80.
    PubMed     Text format     Abstract available


    December 2016
  9. SOARES M, Neves C, Marques IP, Pires I, et al
    Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography.
    Br J Ophthalmol. 2016 Dec 7. pii: bjophthalmol-2016-309424.
    PubMed     Text format     Abstract available


  10. ARICHIKA S, Uji A, Murakami T, Suzuma K, et al
    Correlation of retinal arterial wall thickness with atherosclerosis predictors in type 2 diabetes without clinical retinopathy.
    Br J Ophthalmol. 2016 Dec 2. pii: bjophthalmol-2016-309612.
    PubMed     Text format     Abstract available


    November 2016
  11. LIN AD, Lee AY, Zhang Q, Rezaei KA, et al
    Association between OCT-based microangiography perfusion indices and diabetic retinopathy severity.
    Br J Ophthalmol. 2016 Nov 15. pii: bjophthalmol-2016-309514.
    PubMed     Text format     Abstract available


    October 2016
  12. TOTH G, Szabo D, Sandor GL, Szalai I, et al
    Diabetes and diabetic retinopathy in people aged 50 years and older in Hungary.
    Br J Ophthalmol. 2016 Oct 28. pii: bjophthalmol-2016-309016.
    PubMed     Text format     Abstract available


    September 2016
  13. IACONO P, Parodi MB, Scaramuzzi M, Bandello F, et al
    Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Br J Ophthalmol. 2016 Sep 13. pii: bjophthalmol-2016-308726.
    PubMed     Text format     Abstract available


    August 2016
  14. JORGENSEN CM, Bek T
    Lack of differences in the regional variation of oxygen saturation in larger retinal vessels in diabetic maculopathy and proliferative diabetic retinopathy.
    Br J Ophthalmol. 2016 Aug 23. pii: bjophthalmol-2016-308894.
    PubMed     Text format     Abstract available


  15. XUE K, Yang E, Chong NV
    Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy.
    Br J Ophthalmol. 2016 Aug 16. pii: bjophthalmol-2016-308704.
    PubMed     Text format     Abstract available


    July 2016
  16. POLLACK A, Staurenghi G, Sager D, Mukesh B, et al
    Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
    Br J Ophthalmol. 2016 Jul 7. pii: bjophthalmol-2016-308617.
    PubMed     Text format     Abstract available


    May 2016
  17. ASHRAF M, Souka A, Adelman R
    Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature.
    Br J Ophthalmol. 2016 May 26. pii: bjophthalmol-2016-308388.
    PubMed     Text format     Abstract available


  18. MANSOUR AM, Dedhia C, Chhablani J
    Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema.
    Br J Ophthalmol. 2016 May 17. pii: bjophthalmol-2016-308679.
    PubMed     Text format     Abstract available


    March 2016
  19. BANDELLO F, Corvi F, La Spina C, Benatti L, et al
    Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Br J Ophthalmol. 2016 Mar 7. pii: bjophthalmol-2016-308400.
    PubMed     Text format     Abstract available


    February 2016
  20. AREVALO JF, Lasave AF, Wu L, Acon D, et al
    Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study group.
    Br J Ophthalmol. 2016 Feb 24. pii: bjophthalmol-2015-307950.
    PubMed     Text format     Abstract available


    January 2016
  21. YANG X, Deng Y, Gu H, Ren X, et al
    Relationship of retinal vascular calibre and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study.
    Br J Ophthalmol. 2016 Jan 28. pii: bjophthalmol-2014-306078.
    PubMed     Text format     Abstract available


  22. ROMERO-AROCA P, de la Riva-Fernandez S, Valls-Mateu A, Sagarra-Alamo R, et al
    Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population.
    Br J Ophthalmol. 2016 Jan 14. pii: bjophthalmol-2015-307689.
    PubMed     Text format     Abstract available


    November 2015
  23. DANIS RP, Sadda S, Li XY, Cui H, et al
    Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
    Br J Ophthalmol. 2015 Nov 18. pii: bjophthalmol-2015-306823.
    PubMed     Text format     Abstract available


  24. MEHTA H, Fraser-Bell S, Yeung A, Campain A, et al
    Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
    Br J Ophthalmol. 2015 Nov 4. pii: bjophthalmol-2015-307797.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: